| Sex differences in metabolic regulation and diabetes susceptibility B Tramunt, S Smati, N Grandgeorge, F Lenfant, JF Arnal, A Montagner, ... Diabetologia 63, 453-461, 2020 | 756 | 2020 |
| Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD A Montagner, A Polizzi, E Fouché, S Ducheix, Y Lippi, F Lasserre, ... Gut 65 (7), 1202-1214, 2016 | 694 | 2016 |
| The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway M Dance, A Montagner, JP Salles, A Yart, P Raynal Cellular signalling 20 (3), 453-459, 2008 | 399 | 2008 |
| Metabolic effects of a chronic dietary exposure to a low-dose pesticide cocktail in mice: sexual dimorphism and role of the constitutive androstane receptor C Lukowicz, S Ellero-Simatos, M Régnier, A Polizzi, F Lasserre, ... Environmental health perspectives 126 (6), 067007, 2018 | 147 | 2018 |
| A specific ChREBP and PPARα cross-talk is required for the glucose-mediated FGF21 response A Iroz, A Montagner, F Benhamed, F Levavasseur, A Polizzi, E Anthony, ... Cell reports 21 (2), 403-416, 2017 | 135 | 2017 |
| Reduced phosphatase activity of SHP‐2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1 N Hanna, A Montagner, WH Lee, M Miteva, M Vidal, M Vidaud, B Parfait, ... FEBS letters 580 (10), 2477-2482, 2006 | 135 | 2006 |
| Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals A Montagner, A Korecka, A Polizzi, Y Lippi, Y Blum, C Canlet, ... Scientific reports 6 (1), 20127, 2016 | 129 | 2016 |
| Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature ADR Serra-Nédélec, T Edouard, K Tréguer, M Tajan, T Araki, M Dance, ... Proceedings of the National Academy of Sciences 109 (11), 4257-4262, 2012 | 128 | 2012 |
| Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease A Fougerat, A Montagner, N Loiseau, H Guillou, W Wahli Cells 9 (7), 1638, 2020 | 123 | 2020 |
| Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity M Régnier, A Polizzi, S Smati, C Lukowicz, A Fougerat, Y Lippi, E Fouché, ... Scientific reports 10 (1), 6489, 2020 | 115 | 2020 |
| The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα A Iershov, I Nemazanyy, C Alkhoury, M Girard, E Barth, N Cagnard, ... Nature Communications 10 (1), 1566, 2019 | 101 | 2019 |
| GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation R Kostadinova, A Montagner, E Gouranton, S Fleury, H Guillou, ... Cell & bioscience 2, 1-16, 2012 | 100 | 2012 |
| The liver X receptor: a master regulator of the gut–liver axis and a target for non alcoholic fatty liver disease S Ducheix, A Montagner, V Theodorou, L Ferrier, H Guillou Biochemical pharmacology 86 (1), 96-105, 2013 | 97 | 2013 |
| Perilipin 5 fine-tunes lipid oxidation to metabolic demand and protects against lipotoxicity in skeletal muscle C Laurens, V Bourlier, A Mairal, K Louche, PM Badin, E Mouisel, ... Scientific reports 6 (1), 38310, 2016 | 91 | 2016 |
| The nuclear hormone receptor peroxisome proliferator-activated receptor β/δ potentiates cell chemotactism, polarization, and migration NS Tan, G Icre, A Montagner, BB Heggeler, W Wahli, L Michalik Molecular and cellular biology 27 (20), 7161-7175, 2007 | 87 | 2007 |
| New insights into the role of PPARs A Montagner, G Rando, G Degueurce, N Leuenberger, L Michalik, ... Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 85 (5), 235-243, 2011 | 86 | 2011 |
| Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ NS Tan, M Vázquez-Carrera, A Montagner, MK Sng, H Guillou, W Wahli Progress in Lipid Research 64, 98-122, 2016 | 83 | 2016 |
| The adaptor protein Gab1 couples the stimulation of vascular endothelial growth factor receptor-2 to the activation of phosphoinositide 3-kinase M Dance, A Montagner, A Yart, B Masri, Y Audigier, B Perret, JP Salles, ... Journal of Biological Chemistry 281 (32), 23285-23295, 2006 | 83 | 2006 |
| Hepatic PPARα is critical in the metabolic adaptation to sepsis R Paumelle, JT Haas, N Hennuyer, E Baugé, Y Deleye, D Mesotten, ... Journal of hepatology 70 (5), 963-973, 2019 | 71 | 2019 |
| Insights into the role of hepatocyte PPARα activity in response to fasting M Régnier, A Polizzi, Y Lippi, E Fouché, G Michel, C Lukowicz, S Smati, ... Molecular and cellular endocrinology 471, 75-88, 2018 | 66 | 2018 |
